Postop Nausea Refractory to Standard Prophylaxis
A 34-year-old woman with a history of severe postoperative nausea and vomiting after two prior surgeries undergoes laparoscopic ovarian cystectomy. She received ondansetron 4 mg and dexamethasone 4 mg at induction, and the surgeon infiltrated the port sites with bupivacaine. In the PACU she has two episodes of emesis and reports persistent nausea despite a second dose of ondansetron. She is hemodynamically stable, has a dry surgical field, and is tolerating sips of water.
1. What is your stepwise approach to her refractory nausea, and what is the rationale for each agent?
Read the worked answer
This patient has refractory PONV despite guideline-consistent prophylaxis. The approach should be multimodal and mechanism-based, because repeating the same class (ondansetron) adds little and may be ineffective.
Stepwise:
- Rule out and treat contributors: pain (opioid use), hypovolemia, gastric distension, and blood in the stomach can all drive nausea. Assess pain score, give fluid if indicated, and consider a nasogastric decompression if distended.
- Add a different class: a dopamine antagonist (droperidol or metoclopramide) or an NK1 antagonist (aprepitant) if not already given. Droperidol is effective but requires ECG monitoring for QT prolongation in some settings.
- Antihistamine or anticholinergic: promethazine or scopolamine can be useful, especially if vestibular or opioid-related.
- Consider dexamethasone timing: it was given at induction, which is appropriate; a repeat dose is generally not recommended within 24 hours.
- Nonpharmacologic: acupuncture at P6, ginger, and minimizing stimulation.
The key judgment is not to repeat ondansetron indefinitely and to address the underlying drivers (pain, hydration) alongside antiemetics.
2. She asks why she got nauseated despite 'all the medicine.' How do you explain it, and what do you change for next time?
Read the worked answer
Explain that PONV is multifactorial-anesthetic agents, surgical manipulation, pain, and individual susceptibility (her prior history is the strongest predictor) all contribute, and no single drug blocks every pathway. Two prophylactic agents reduce but do not eliminate risk.
For future anesthetics:
- Risk-stratify using a validated score (Apfel) and use multimodal prophylaxis with 2-3 agents from different classes for high-risk patients.
- Anesthetic technique: consider total intravenous anesthesia with propofol instead of volatile agents, which reduces PONV; minimize nitrous oxide and opioids.
- Multimodal analgesia with regional blocks, NSAIDs, and acetaminophen to reduce opioid use.
- Adequate hydration and avoidance of hypotension.
- Preemptive antiemetic plan documented for the next procedure.
Document her history prominently so future providers see it. The judgment point is that prior PONV is the strongest predictor and should drive a more aggressive, mechanism-diverse plan next time-not just 'more ondansetron.'